Mangoceuticals Inc. unveils PeachesRx for personalized care and GLP-1 weight loss treatments

Image source: peachesrx.com
WT default author logo
Women's Tabloid News Desk

Mangoceuticals, Inc., a company known for its telemedicine-based men’s wellness brand, MangoRx, is stepping into the women’s healthcare space with the official launch of PeachesRx. This new brand is designed to provide innovative and convenient health solutions tailored specifically for women, starting with compounded GLP-1 receptor agonists—a class of medications that support weight loss by regulating appetite and glucose metabolism.

With research indicating that nearly 70% of GLP-1 prescriptions for weight loss are written for women, PeachesRx is positioned to meet this rising demand. The brand’s telehealth platform aims to provide an accessible, affordable, and medically backed approach to weight management, ensuring treatments are tailored to women’s unique metabolic needs.

Jacob Cohen, CEO and Founder of Mangoceuticals, highlighted the company’s vision for this expansion. “The launch of PeachesRx is the natural next step in Mangoceuticals’ expansion as we continue to redefine direct-to-consumer healthcare solutions,” he said. “We’ve seen the success of our telehealth platform for men, and we believe there is an even greater opportunity in women’s health. As we have seen with MangoRx in the men’s health market, brand trust, accessibility, and innovative product offerings have been key to driving MangoRx’s success. PeachesRx will follow this blueprint, ensuring that women can confidently access clinically proven treatments tailored to their needs.”

Amanda Hammer, COO of Mangoceuticals, emphasized the importance of improving healthcare accessibility for women. “Women’s healthcare has been underserved for too long. With PeachesRx, we are transforming access by providing seamless, confidential, and medically backed care,” she stated. “Our goal is to bring the same level of innovation, affordability, and accessibility that has driven our success in men’s wellness.”

PeachesRx will offer its treatments through a secure telemedicine platform, allowing patients to consult with licensed physicians. Approved prescriptions will be discreetly processed and shipped through the company’s partner compounding pharmacy, ensuring a streamlined and hassle-free experience for users.

PeachesRx’s telemedicine services will be available through its dedicated platform, www.peachesrx.com, where women can explore treatment options designed to support their health and well-being in a discreet and convenient manner.

Share:

Related Insights

Clue secures major investment from Verdane to support next phase of expansion

Xella Health raises $3.7 million ahead of Spring 2026 precision health launch

Pomelo Care raises $92 million series C at $1.7 billion valuation to expand women’s and children’s healthcare model

FDA grants approval for Addyi to treat HSDD in postmenopausal women

Freya Pharma Solutions rebrands as Arletta Pharma Solutions as company enters next stage of women’s healthcare development

Sofinnova Partners closes €650 million flagship fund as capital raised reaches €1.5bn in one year

Verastem Oncology sets price for $90 million Public Offering of shares and pre-funded warrants

The rise of the UK’s Femtech market and emerging trends